Loading...
Date of Award
Spring 2020
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Jodi Freeman, MMS, PA-C
Abstract
Endometriosis is a chronic condition that involves the growth, adhesion and development of endometrial glands and stroma outside of the uterine cavity. This misplaced tissue causes women to have menorrhagia, dysmenorrhea, nausea, vomiting, fatigue, dyspareunia, infertility and chronic pelvic pain. The current first line treatment for women with endometriosis is hormonal therapy that impedes a woman’s ability to conceive. Therefore, this review analyzes the use of N-acetylcysteine [I] for symptomatic relief and less fertility risks [O] for young women with endometriosis who wish to conceive [P] when compared to traditional hormonal therapy [C].
Recommended Citation
Pietraccini, Amelia, "The Efficacy of N-acetylcysteine as a New Therapeutic Option for Women With Endometriosis Who Wish to Achieve Pregnancy" (2020). Capstone Showcase. 88.
https://scholarworks.arcadia.edu/showcase/2020/pa/88
The Efficacy of N-acetylcysteine as a New Therapeutic Option for Women With Endometriosis Who Wish to Achieve Pregnancy
Endometriosis is a chronic condition that involves the growth, adhesion and development of endometrial glands and stroma outside of the uterine cavity. This misplaced tissue causes women to have menorrhagia, dysmenorrhea, nausea, vomiting, fatigue, dyspareunia, infertility and chronic pelvic pain. The current first line treatment for women with endometriosis is hormonal therapy that impedes a woman’s ability to conceive. Therefore, this review analyzes the use of N-acetylcysteine [I] for symptomatic relief and less fertility risks [O] for young women with endometriosis who wish to conceive [P] when compared to traditional hormonal therapy [C].